# BAY2586116 Nasal Spray and OSA Severity

> **NCT05527457** · PHASE1 · COMPLETED · sponsor: **Flinders University** · enrollment: 10 (actual)

## Conditions studied

- Sleep Apnea, Obstructive

## Interventions

- **DRUG:** BAY2586116
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05527457
- **Lead sponsor:** Flinders University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-31
- **Primary completion:** 2022-12-20
- **Final completion:** 2022-12-20
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05527457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05527457, "BAY2586116 Nasal Spray and OSA Severity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05527457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*